Anakinra for Refractory Cytokine Release Syndrome or Immune Effector Cell-Associated Neurotoxicity Syndrome after Chimeric Antigen Receptor T Cell TherapyNicolas Gazeau, Jordan Gauthier, Emily C. Liang et al.|Transplantation and Cellular Therapy|2023Cited by 144
Real‐world evidence of tisagenlecleucel for the treatment of relapsed or refractory large B‐cell lymphomaGloria Iacoboni, Guillermo Villacampa, Núria Martínez‐Cibrián et al.|Cancer Medicine|2021Cited by 134
Outcomes among adult recipients of CAR T-cell therapy for Burkitt lymphomaLaura Samples, Mazyar Shadman, Hossein Sadrzadeh et al.|Blood|2025Cited by 15
CD19 CAR-T Cell Therapy Is Effective in Richter Transformation: A Multicenter Retrospective Analysis By the European Research Initiative on Chronic Lymphocytic LeukemiaOfrat Beyar‐Katz, Yair Herishanu, Abraham Avigdor et al.|Blood|2024Cited by 4
CD19 CAR T‐Cell Therapy in Richter Transformation: A Multicentre Retrospective Analysis by the European Research Initiative on Chronic Lymphocytic LeukaemiaOfrat Beyar‐Katz, Yair Herishanu, Ohad Benjamini et al.|Journal of Cellular and Molecular Medicine|2025Cited by 3